Who owns Blueprint Medicines Corporation NPV?
- CUSIP Number: 096cvr048
Tip: Access positions for across all investors
Analyze quarterly positions in Blueprint Medicines Corporation with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Blueprint Medicines Corporation stock
Who bought or sold Blueprint Medicines Corporation NPV this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| GAMMA Investing | 271.00 | $0 | 100% | Jun 2026 |
|
| Golden State Equity Partners | 11.00 | $0 | 100% | Mar 2026 |
|
| Massmutual Trust | 9.00 | $0 | 0% | Jun 2026 |
|
| Keating Financial Advisory Services | 4.00 | $0 | 100% | Mar 2026 |
|
| Private Trust Co Na | 1.00 | $0 | 0% | Mar 2026 |
|
Who sold out of Blueprint Medicines Corporation?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Flagship Wealth Advisors | Dec 2025 | 443.00 | $0 |
| Wall Street Access Asset Management | Dec 2025 | 300.00 | $0 |